Litcius/Paper detail

Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern

Jingwen Ai, H. C. Zhang, Qiran Zhang, Yi Zhang, Ke Lin, Zhangfan Fu, Jieyu Song, Yuanhan Zhao, Mingxiang Fan, Hongyu Wang, Chao Qiu, Yang Zhou, Wenhong Zhang

2021Cell Research101 citationsDOIOpen Access PDF

Abstract

Recombinant protein subunit vaccine booster following two

Topics & Concepts

BiologyVirologyRecombinant DNAProtein subunitTiterBooster (rocketry)Booster doseNeutralizing antibodyCoronavirus disease 2019 (COVID-19)ImmunologyInfectious disease (medical specialty)VirusGeneticsDiseaseGeneMedicinePhysicsAstronomyPathologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesPeripheral Neuropathies and Disorders
Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern | Litcius